✦ LIBER ✦

Phase I evaluation of ICRF-187 (NSC-169780) in patients with advanced malignancy

✍ Scribed by Jean Liesmann; Robert Belt; Charles Haas; Barth Hoogstraten

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 366 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810415)47:8<1959::aid-cncr2820470808>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of dactinomycin intraven

A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies

✍ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered

Evaluation of transsphenoidal hypophysec

Evaluation of transsphenoidal hypophysectomy in the management of patients with advanced malignant melanoma

✍ David H. Lawson; Daniel W. Nixon; Marcus L. Black; George T. Tindall; David A. B 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Transsphenoidal hypophysectomy was performed in 13 patients with advanced malignant melanoma. Although three minor responses were observed, there were no complete or partial responses. All three patients with bone pain had a decrease in discomfort lasting 1-2 months. All five patients with minor res

Phase II study of high-dose tamoxifen (N

Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

✍ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas

A Phase I study of the combination N-(ph

A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancer

✍ Edward T. Creagan; MICHAEL J. O'Connell; John S. Kovach 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 1 views

A Phase I trial of weekly lomustine in p

A Phase I trial of weekly lomustine in patients with advanced cancer

✍ Charles A. Koller; Carolyn C. Gorski; Robert S. Benjamin; Sewa S. Legha; Nichola 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 2 views

Phase I study to evaluate multiple regim

Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors : A potential broadly active regimen for advanced solid tumor malignancies

✍ Sridhar Mani; Nicholas J. Vogelzang; Donna Bertucci; Walter M. Stadler; Richard 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views